BioArctic AB (publ)

SSE:BIOA-B.ST

227.8 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 49.84429.63911.024208.8382.706393.4262.09218.2254.243.7374.7063.9527.3127.1778.36110.5497.00736.43126.42220.631171.33263.388515.3294.04552.30152.30351.02131.49332.01826.17494.441.1821.0014.996
Cost of Revenue 4.8112.23662.17815.46415.52930.13714.14130.88814.3714.92716.52813.88413.35511.29913.37610.66415.71610.48620.97113.4888.02529.93848.0342.73828.45226.13727.08512.66715.6920.2660.238000
Gross Profit 45.03327.403-51.154193.374-12.823363.289-12.051187.337-10.13-11.19-11.822-9.932-6.043-4.122-5.015-0.115-8.70925.9455.4517.143163.30733.45467.2951.30723.84926.16623.93618.82616.32625.90894.2021.1821.0014.996
Gross Profit Ratio 0.9030.925-4.640.926-4.7390.923-5.7660.858-2.389-2.994-2.512-2.513-0.826-0.574-0.6-0.011-1.2430.7120.2060.3460.9530.5280.9070.5460.4560.50.4690.5980.510.990.997111
Reseach & Development Expenses 83.52362.97328.49715.46415.52930.13714.14130.88814.3714.92716.52813.88413.35511.2990000000000037.25636.83921.42017.35622.0848.86611.98211.358
General & Administrative Expenses 21.426.2780052.00623.33907.2768.4377.4527.4194.7846.6426.0086.0854.3826.1476.7557.8047.0138.3787.97310.0426.6757.2147.04712.9697.9058.8283.7616.8563.3263.1022.181
Selling & Marketing Expenses 15.54312.5350010.2469.03300000000000000000000.3510.4850.21600.3430.3420.3390.3440.345
SG&A 36.94338.81357.33651.80783.04759.06142.0637.2768.4377.4527.4194.7846.6426.0086.0854.3826.1476.7557.8047.0138.3787.97310.0426.6757.2147.39813.4548.1218.8284.1047.1983.6653.4462.526
Other Expenses -120.46600088.04762.70439.10447.02727.1825.42920.24722.69321.12719.01316.36416.2123.08315.39520.16910.6428.1418.14229.89511.50910.19-11.255-18.0551.3335.0242.98-18.384-1.15400
Operating Expenses 120.466100.50228.49762.36188.04762.70439.10454.30335.61732.88127.66627.47727.76925.02122.44920.59229.2322.1527.97317.65336.51916.11539.93718.18417.40433.39932.23830.87413.85224.4410.89811.37712.24411.25
Operating Income -75.433-73.098-79.651131.012-100.869300.584-60.658133.034-45.747-44.071-39.358-37.409-33.812-29.144-30.159-20.708-37.943.794-21.074-10.51126.78717.335430.3233.1256.44618.90314.7320.6192.4751.46997.333-10.194-11.243-6.254
Operating Income Ratio -1.513-2.466-7.2250.627-37.2760.764-29.0230.61-10.789-11.793-8.363-9.466-4.624-4.061-3.607-1.963-5.4150.104-0.798-0.5090.740.2730.8350.3520.1230.3610.2890.020.0770.0561.031-8.624-11.232-1.252
Total Other Income Expenses Net 7.00315.613.9979.5868.4793.3482.7873.761-0.088-0.185-0.159-0.177-0.3860.037-3.7870.011-1.4080.8070.984-0.0310.8590.0732.5510.1130.1950.909-3.486-0.6960.54-0.01113.0920.1880.1730.128
Income Before Tax -68.43-57.488-75.654140.598-92.39303.932-57.871136.795-45.835-44.256-39.622-37.586-34.198-29.106-31.251-20.696-39.3474.602-21.538-10.541127.64717.408429.90433.2366.6419.81315.297-0.0773.0141.45796.396-10.007-11.07-6.127
Income Before Tax Ratio -1.373-1.94-6.8630.673-34.1430.773-27.6890.627-10.81-11.843-8.419-9.511-4.677-4.055-3.738-1.962-5.6150.126-0.815-0.5110.7450.2750.8340.3530.1270.3790.3-0.0020.0940.0561.021-8.466-11.059-1.226
Income Tax Expense -0.0050.07511.58915.6489.92510.0750.0060.0040.0020.185-20.667-0.015-0.021-0.02-18.052-0.045-1.1241.048-4.443-2.2127.3823.77894.6997.3791.5194.3943.4610.0390.6930.34121.431-2.2492.3781.313
Net Income -68.425-57.563-87.243124.95-102.315293.857-57.877136.791-45.837-44.441-18.955-37.571-34.177-29.086-13.198-20.65-38.2223.554-17.096-8.331100.26613.629335.20525.8565.12115.41911.837-0.1162.3211.11674.965-7.758-8.692-4.814
Net Income Ratio -1.373-1.942-7.9140.598-37.810.747-27.6920.627-10.811-11.892-4.028-9.507-4.674-4.053-1.579-1.958-5.4550.098-0.647-0.4040.5850.2150.650.2750.0980.2950.232-0.0040.0720.0430.794-6.563-8.683-0.964
EPS -0.77-0.65-0.991.42-1.163.33-0.661.55-0.52-0.5-0.18-0.43-0.39-0.33-0.15-0.23-0.430.04-0.19-0.0951.140.153.760.290.060.180.13-0.0010.0260.0130.85-0.088-0.14-0.076
EPS Diluted -0.77-0.65-0.991.41-1.163.31-0.661.54-0.52-0.5-0.18-0.42-0.38-0.33-0.15-0.23-0.430.04-0.19-0.0951.140.153.760.290.060.180.13-0.0010.0260.0130.85-0.088-0.14-0.076
EBITDA -67.97-57.374-74.809145.525-96.305310.463-54.078140.601-41.988-40.509-36.21-34.054-30.551-25.6-27.898-17.625-35.3757.413-19.213-7.826130.36920.036430.87534.2027.18420.17615.6370.6193.4651.46996.398-10.005-10.878-5.878
EBITDA Ratio -1.364-1.936-6.7860.697-35.5890.789-25.8750.644-9.903-10.84-7.694-8.617-4.178-3.567-3.337-1.671-5.0490.203-0.727-0.3790.7610.3160.8360.3640.1370.3860.3060.020.1080.0561.021-8.464-10.867-1.177